Catalytic Hydrocarbon Functionalization with Gold Complexes
CDCl3): δ = 15.1 (CH3CH2O), 39.9 (CH3N), 53.5 (CH2CO2Et), (400 MHz, CDCl3): δ = 1.32 (t, J = 7.2 Hz, 3 H, CH3CH2O), 2.01
63.3 (CH3CH2O), 123.5 (CH, imidazole), 123.7 (CH, imidazole),
168.7 (C=O), 183.1 (C-carbene) ppm.
(s, 6 H, CH3), 2.32 (s, 3 H, CH3), 4.28 (q, J = 7.2 Hz, 2 H,
CH3CH2O), 5.09 (s, 2 H, CH2CO2Et), 6.92 (d, J = 1.7 Hz, 1 H,
CH, imidazole), 6.95 (s, 2 H, CH, arom.), 7.24 (d, J = 1.7 Hz, 1 H,
CH, imidazole) ppm. 13C{1H} NMR (100 MHz, CDCl3): δ = 14.3
(CH3CH2O), 18.0 (CH3), 21.4 (CH3), 52.1 (CH2CO2Et), 62.7
(CH3CH2O), 122.1, 122.7, 129.7, 134.6, 135.0, 140.0, 167.1 (C=O),
173.4 (C-carbene) ppm.
[N-(Ethylacetyl)-NЈ-(mesityl)imidazolin-2-ylidene]silver Bromide (7):
A mixture of 3 (116 mg, 0.33 mmol) and silver oxide (93 mg,
0.40 mmol) in CH2Cl2 (15 mL) was stirred at room temperature for
24 h in the dark. After filtration with Celite and solvent removal,
complex 7 was isolated as an off-white solid (93 mg, 60%). 1H
NMR (400 MHz, CD2Cl2): δ = 1.30 (t, J = 7 Hz, 3 H, CH3CH2O),
1.82 (br. s, 6 H, CH3), 2.38 (s, 3 H, CH3), 4.25 (q, J = 7 Hz, 2 H,
CH3CH2O), 5.02 (s, 2 H, CH2CO2Et), 6.85–6.99 (m, 2 H, CH,
arom., CH, imidazole), 7.35–7.38 (m, 2 H, CH, arom., CH, imid-
[N-(2,6-Diisopropylphenyl)-NЈ-(ethylacetyl)imidazolin-2-ylidene]gold
Chloride (12): A method of preparation similar to that used above,
with 8 as the starting material, gave 12 as a yellowish solid (120 mg,
67%). C19H26AuClN2O2·CH2Cl2 (631.5): calcd. C 38.0, H 4.43, N
4.43; found C 39.25, H 4.53, N 4.43. 1H NMR (400 MHz, CD2Cl2):
δ = 1.06 [d, J = 6.8 Hz, 6 H, CH3(CH3)2], 1.20 [d, J = 6.8 Hz, 6
H, CH3(CH3)2], 1.22–1.26 (m, 2 H, CH3CH2O), 2.36 [sept, J =
6.8 Hz, 2 H, CH(CH3)2], 4.23 (q, J = 7.2 Hz, 2 H, CH3CH2O), 5.02
(s, 2 H, CH2CO2Et), 7.04 (d, J = 1.9 Hz, 1 H, CH, imidazole), 7.24
(d, J = 1.9 Hz, 1 H, CH, imidazole), 7.31–7.34 (m, 2 H, CH,
arom.), 7.42 (t, J = 7.6 Hz, 1 H, CH, arom.) ppm. 13C{1H} NMR
(100 MHz, CDCl3): δ = 13.8 (CH3CH2O), 24.0 [CH(CH3)2], 24.2
[CH(CH3)2], 28.3 [CH(CH3)2], 52.0 (CH2CO2Et), 62.4
(CH3CH2O), 121.7 (CH, imidazole), 123.7 (CH, imidazole), 124.1
(CH, arom.), 130.6 (CH, arom.), 145.9 (CH, arom.), 168.9 (C=O),
175.5 (C-carbene) ppm.
azole) ppm. 13C{1H} NMR (100 MHz, CD2Cl2):
δ = 13.9
(CH3CH2O), 17.3 (CH3), 20.9 (CH3), 52.5 (CH2CO2Et), 62.3
(CH3CH2O), 122.6, 122.9, 128.8, 129.2, 134.8, 135.1, 135.3, 167.4
(C=O), 183.8 (br. s, C-carbene) ppm.
[N-(2,6-Diisopropylphenyl)-NЈ-(Ethylacetyl)imidazolin-2-ylidene]-
silver Bromide (8): Following the above protocol, 4 (51 mg,
0.13 mmol) and silver oxide (35 mg, 0.15 mmol) were stirred at
40 °C for 12 h in the dark in CH2Cl2 (15 mL) as the solvent. Fil-
tration through Celite prior to removal of volatiles afforded com-
1
plex 8 as an off-white solid (58.7 mg, 90%). H NMR (400 MHz,
CDCl3): δ = 1.13 [d, J = 7.2 Hz, 6 H, CH(CH3)2], 1.23 [d, J =
7.2 Hz, 6 H, CH(CH3)2], 1.35 (t, J = 7.2 Hz, 3 H, CH3CH2O), 2.40
[sept, J = 7.2 Hz, 2 H,CH(CH3)2], 4.31 (q, J = 7.2 Hz, 2
H,CH3CH2O), 5.03 (s, 2 H, CH2CO2Et), 7.04 (br. s, 1 H, CH, imid-
azole), 7.25–7.27 (m, 3 H, CH, arom., CH, imidazole), 7.47 (t, J =
7.6 Hz, 1 H, CH, arom.) ppm. 13C{1H} NMR (100 MHz, CDCl3):
δ = 14.07 (CH3CH2O), 24.3 [CH(CH3)2], 24.6 [CH(CH3)2], 28.2
[CH(CH3)2], 52.6 (CH2CO2Et), 62.6 (CH3CH2O), 121.9 (CH, imid-
azole), 122.0 (CH, imidazole), 124.3 (CH, arom.), 130.6 (CH,
arom.), 134.4 (CH, arom.), 145.7 (CH, arom.), 167.2(C=O), 183.6
(br. s, C-carbene) ppm.
Catalytic Experiments. (a) Benzene: An equimolar mixture of the
gold complex 9–12 and NaBArЈ4 (0.025 mmol) was dissolved in
neat benzene (1–3 mL). After 15 min of stirring, EDA (0.5 mmol)
was added in one portion. After 12 h of additional stirring, the
mixture was analyzed by GC. The volatile components were re-
moved, and the residue analyzed by NMR spectroscopy to identify
the products.[3b]
(b) n-Hexane: An equimolar mixture of the gold complex 9–12 and
NaBArЈ4 (0.025 mmol) was dissolved in a mixture of CH2Cl2
(5 mL) and n-hexane (5 mL). After 15 min of stirring, EDA
(0.5 mmol) was added with the aid of a syringe pump (dissolved in
5 mL of CH2Cl2 and hexane, 1:1) for 24 h. The mixture was ana-
lyzed by GC and NMR spectroscopy.[3c]
[N,NЈ-Bis(ethylacetyl)imidazolin-2-ylidene]gold Chloride (9): A mix-
ture of the silver complex 5 (102 mg, 0.33 mmol) and (dimethyl
sulfide)gold(I) chloride (115 mg, 0.39 mmol) in dichloromethane
(50 mL) was stirred for 3 h at room temperature. After filtration,
activated carbon was added to the filtrate and the mixture was
filtered through Celite. The volatiles were then removed under re-
duce pressure to afford complex 9 as a white solid (30.1 mg, 64%).
C11H16AuClN2O4 (472.05): calcd. C 27.95, H 3.41, N 5.93; found
Computational Details: Calculations were performed with the
GAUSSIAN 09 series of programs.[17] The geometries were opti-
mized at the DFT level using the B3LYP functional.[18] The
LANL2DZ basis set, which includes the relativistic effective core
potential (ECP) of Hay and Wadt and employs a split-valence
(double-ζ) basis set, was used for Au.[19]
1
C 27.71, H 3.49, N 6.66. H NMR (400 MHz, CDCl3): δ = 1.32 (t,
J = 7.2 Hz, 6 H, CH3CH2O), 4.26 (q, J = 7.2 Hz, 4 H, CH3CH2O),
5.00 (s, 4 H, CH2CO2Et), 7.10 (s, 2 H, CH, imidazole) ppm.
13C{1H} NMR (100 MHz, CDCl3): δ = 14.3 (CH3CH2O), 52.1
(CH2CO2Et), 62.7 (CH3CH2O), 122.3 (CH, imidazole), 166.9
(C=O), 174.4 (C-carbene) ppm.
Acknowledgments
We thank Ministerio de Ciencia
e Innovación (MICINN)
[N-(Ethylacetyl)-NЈ-(methyl)imidazolin-2-ylidene]gold Chloride (10):
Following the procedure described for 9, complex 10 was prepared
(CTQ2008-00042BQU, CTQ2010-16088/BQU, Consolider Ingenio
2010 grant number CSD-2006-0003), Junta de Andalucía (P07-
FQM-02870), the Agència de Gestió d’Ajuts Universitaris i de Re-
serca (AGAUR) (2009 SGR 47), and the ICIQ Foundation for fin-
ancial support. M. D. R. thanks the Ministerio de Educación y Ci-
encia (MEC) for a FPU fellowship.
from
6 and isolated as a white solid (75.1 mg, 60%).
C8H12AuClN2O2 (400.03): calcd. C 23.98, H 3.02, N 6.99; found C
23.61, H 3.21, N 6.88. 1H NMR (400 MHz, CDCl3): δ = 1.32 (t, J =
7.2 Hz, 3 H, CH3CH2O), 3.84 (s, 3 H, CH3N), 4.24 (q, J = 7.2 Hz, 2
H, CH3CH2O), 4.97 (s, 2 H, CH2CO2Et), 7.00 (d, J = 1.9 Hz, 1 H,
CH, imidazole), 7.05 (d, J = 1.9 Hz, 1 H, CH, imidazole) ppm.
13C{1H} NMR (100 MHz, CDCl3): δ = 14.3 (CH3CH2O), 38.8
(CH3N), 52.0 (CH2CO2Et), 62.8 (CH3CH2O), 122.1 (CH, imid-
azole), 167.5 (C=O), 173 (C-carbene) ppm.
[1] J. C. Y. Lin, R. T. W. Huang, C. S. Lee, A. Bhattacharyya, W. S.
Hwang, I. J. B. Lin, Chem. Rev. 2009, 109, 3561–3598.
[2] For recent examples, see: a) I. I. F. Boogaerts, G. C. Fortman,
M. R. L. Furst, C. S. J. Cazin, S. P. Nolan, Angew. Chem. Int.
Ed. 2010, 49, 8674–8677; b) T. Ohishi, L. Zhang, M. Nishiura,
Z. Hou, Angew. Chem. Int. Ed. 2011, 50, 8114–8117; c) M. Sai,
H. Yorimitsu, K. Oshima, Angew. Chem. Int. Ed. 2011, 50,
3294–3298; d) W.-Z. Zhang, W.-J. Li, X. Zhang, H. Zhou, X.-
[N-(Ethylacetyl)-NЈ-(mesityl)imidazolin-2-ylidene]gold
Chloride
(11): This complex was prepared as above, using 7 as the starting
material; yield 163.5 mg, 65%. C16H20AuClN2O2 (504.1): calcd. C
38.07, H 3.99, N 5.55; found C 38.48, H 4.36, N 5.83. 1H NMR
Eur. J. Inorg. Chem. 2012, 1380–1386
© 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjic.org
1385